TWST 8-K: SEC filing

Twist Bioscience

Filed with the SEC on Nov 12, 2026 · accession 0001581280-26-000053

TWST filed a 8-K (current report) with the SEC on Nov 12, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Summary of the filing

Twist Bioscience reported its financial results for the fiscal fourth quarter and full year ended September 30, 2026, via a press release furnished as Exhibit 99.1 to this Form 8-K.

For details, click here →How to read a 8-K →

Key details

RegistrantTwist Bioscience Corporation

Chief legal officer and corporate secretaryDennis Cho

✦ Ask GOAX AI about this filing — what it means for TWST, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for TWST?

Click here

Frequently asked questions

What did TWST file with the SEC on Nov 12, 2026?

TWST filed a 8-K (SEC filing). Twist Bioscience reported its financial results for the fiscal fourth quarter and full year ended September 30, 2026, via a press release furnished as Exhibit 99.1 to this Form 8-K.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Other TWST SEC filings

Get alerts when TWST files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days

TWST overview TWST analysis TWST news Latest SEC filings